ZCM
KYNB

Ziegler Capital Management’s Kyntra Bio KYNB Stock Holding History

Ziegler Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-972
Closed -$647K – 433
2021
Q2 		$647K Buy
972
+270
+38% +$156K 0.02% 373
2021
Q1 		$609K Buy
+702
New +$747K 0.02% 375

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ziegler Capital Management's KYNB Position: Q3 2021 in Review

Ziegler Capital Management sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 972 shares — an estimated $647K sold.

Ziegler Capital Management first reported a position in KYNB in Q1 2021 and held it in 2 quarters. The position peaked at $647K in Q2 2021. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Ziegler Capital Management reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Ziegler Capital Management sold 972 Kyntra Bio shares in Q3 2021, an estimated $647K.
  • Ziegler Capital Management first reported a position in Kyntra Bio in Q1 2021 and held it in 2 quarters.
  • Ziegler Capital Management's Kyntra Bio position peaked at $647K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Ziegler Capital Management's 13F filing for Q3 2021, filed 27 Oct 2021.